LivaNova (LIVN) Net Income towards Common Stockholders (QoQ) (2015 - 2026)
LivaNova (LIVN) Net Income towards Common Stockholders (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 369.57% |
| Mar 31, 2026 | -25.14% |
| Dec 31, 2025 | 15.37% |
| Sep 30, 2025 | -1.37% |
| Jun 30, 2025 | 108.30% |
| Mar 31, 2025 | -685.61% |
| Dec 31, 2024 | 69.80% |
| Sep 30, 2024 | 101.17% |
| Jun 30, 2024 | 139.03% |
| Mar 31, 2024 | -356.28% |
| Dec 31, 2023 | 324.49% |
| Sep 30, 2023 | -715.89% |
| Jun 30, 2023 | -84.01% |
| Mar 31, 2023 | 337.69% |
| Dec 31, 2022 | 101.57% |
| Sep 30, 2022 | -751.47% |
| Jun 30, 2022 | 443.73% |
| Mar 31, 2020 | -632.09% |
| Dec 31, 2018 | -13.05% |
| Sep 30, 2018 | 79.74% |